ÂÜÀòÂÒÂ×

Basavaraj (Raj) Binjawadagi DVM PhD is a seasoned veterinary immunologist and vaccine developer with extensive experience in pre-clinical infectious disease studies, vaccine efficacy, and safety assessments. Currently serving as a Study Director at Noble Life Sciences Inc., Basavaraj leads non-GLP and GLP compliant studies focused on infectious diseases and antivirals. Previous roles include Scientist-II at Novavax, where Basavaraj contributed to vaccine strategies for human viruses, and R&D Scientist-II at CEVA SANTE ANIMALE, specializing in vaccine innovation for swine and poultry. Basavaraj has a strong academic background, with a PhD in Comparative and Veterinary Medicine from The Ohio State University, complemented by a Graduate Certificate in Animal Health Regulatory Affairs from Kansas State University and an ongoing MBA in Organizational Leadership at Rockhurst University. Notable achievements include the development of multiple vaccine candidates with patent applications filed and collaborations established across various institutions.